‘Bipolar androgen therapy’ helps patients with tumours that are resistant to conventional hormone treatments.
Highlights
C&EN: Copper finally joins the metallocene club
17 February 2026More than 70 years after ferrocene’s discovery, cuprocene fills a long-standing gap in the sandwich menu.
C&EN: Lighting a better path for biobased furans
16 January 2026Photocatalytic hydrolysis offers a shortcut for renewable chemicals.
C&EN: Gas looping boosts efficiency of carbon nanotube production
22 December 2025Methane pyrolysis reactor recycles process gases to improve output of nanotubes and hydrogen.
C&EN: Enhanced rock weathering shows little climate benefit in large trial
18 December 20253-year Swiss study underscores the importance of site selection to maximize CO2 sequestration.
Nature Nanotechnology: Brain–computer interfaces race to the clinic
12 December 2025Advances in materials science, microelectronics and semiconductor manufacturing are helping these devices to benefit patients.
TESTIMONIALS
“As an editor and reporter, Mark Peplow is fast, accurate, and versatile. He covers science policy and pure research with equal passion, and his writing combines a scientist’s precision with a journalist’s verve.” Tim Appenzeller
Former Chief Magazine Editor at Nature, now News Editor at Science
"Mark guided me through some of the most challenging stories I've written. These are pieces I might not have attempted were it not for his steady editorial hand." Linda Nordling
Freelance Journalist, South Africa
“Working with Mark is never anything other than a pleasure. He is the kind of editor that writers hope for: able to identify what needs fixing and what doesn’t, bringing to bear a wealth of knowledge, always clear, prompt and easy to talk with. Much of that comes from being a splendid writer himself.”
Philip Ball
Freelance Science Writer
